Total Funding
64
53
Total FundingNon-equity Assistance raised
Growth Score
-10 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
93722
Accelerating the availability of new treatments to the 350 million rare disease sufferers around the world.
- Vahan Simonyan: Chief Scientist
- Robert Chu: Founder and CEO
About the Company
We empower patients to reclaim ownership of their medical data, connect directly with research studies, and be compensated for sharing their data.
We are setting the standard for Real World Evidence, an achievement that will substantially reduce the amount of time and costs for new life-saving drugs to reach patients with rare diseases.
By
improving the collection, quality and sharing of RWE, we enable the healthcare system to move away from the current linear process of drug approvals to a new iterative model where trustworthy digital health data is shared in real time between patients, manufacturers and regulators.
Want to find out more? Get in touch!
